CBDMD INC (YCBD)
AMEXHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
$0.48-1.12%
Close 2026-09-04 · 1-day change
AMEXHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-09-04
QuarterlyIQ Insights · YCBD
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||
| Revenues | 20.9 | 19.2 | 19.5 | 24.2 | 35.4 | 44.5 | 41.9 | 23.7 | 0.5 | 4.5 |
| Total Revenues | 20.9 | 19.2 | 19.5 | 24.2 | 35.4 | 44.5 | 41.9 | 23.7 | 0.5 | 4.5 |
| Cost of Revenues | 8.9 | 7.2 | 7.5 | 9.2 | 13.1 | 14.5 | 15.5 | 9.1 | 0.1 | 1.4 |
| Gross Profit | 12.1 | 12.0 | 12.0 | 15.0 | 22.3 | 30.0 | 26.4 | 14.5 | 0.4 | 3.1 |
| Operating Expenses & Income | ||||||||||
| Operating Income | (2.9) | (2.2) | (3.3) | (22.5) | (78.3) | (19.6) | (17.6) | (14.8) | (1.8) | (1.4) |
| Earnings from Continuing Operations | ||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | 0.0 | 0.5 |
| Asset Writedown | — | — | — | — | — | — | 0.8 | 0.5 | 0.0 | 0.1 |
| EBT, Incl. Unusual Items | (2.9) | (2.0) | (3.7) | (22.9) | (70.1) | (23.4) | 12.7 | (47.8) | — | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | (0.9) | 1.3 | (2.4) | 0.0 | 0.0 |
| Earnings from Continuing Operations | — | — | — | — | — | — | — | — | 0.5 | 0.4 |
| Net Income | ||||||||||
| Net Income | (2.9) | (2.0) | (3.7) | (22.9) | (70.1) | (23.4) | 12.6 | (51.4) | 0.1 | (1.4) |
| Per Share | ||||||||||
| Basic EPS | (0.27) | (1.09) | (1.79) | (13.32) | (55.80) | (0.47) | 0.28 | (2.82) | — | — |
| Diluted EPS | — | (1.09) | (1.79) | (13.32) | (55.80) | (0.47) | 0.28 | 0.00 | — | — |
| Basic Weighted Avg Shares | 10.6 | 4.0 | 4.3 | 2.0 | 1.3 | 54.9 | 44.1 | 17.9 | — | — |
| Diluted Weighted Avg Shares | — | 4.0 | 4.3 | 2.0 | 1.3 | 54.9 | 45.2 | 17.9 | — | — |
| Supplemental | ||||||||||
| EBITDA | — | — | — | — | — | (18.6) | (16.9) | (14.5) | (1.6) | (1.3) |
| EBIT | (2.9) | (2.2) | (3.3) | (22.5) | (78.3) | (19.6) | (17.6) | (14.8) | (1.8) | (1.4) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 3.8% | 10.6% | 4.9% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.